Moreover, SIRT3 assumes a critical role in modulating glycolysis in pancreatic cancer, particularly by counteracting the tumor-promoting consequences of dysregulated glycolytic activity. The gene discussed is SIRT3; the disease is familial pancreatic carcinoma.